login
login

Europe Daily Bulletin No. 12768

24 July 2021
Contents Publication in full By article 13 / 26
EU RESPONSE TO COVID-19 / Health
European Medicines Agency approves Moderna’s vaccine for use in 12-17 year olds
23/07/2021 (Agence Europe)

23/07/2021 (Agence Europe)The European Medicines Agency (EMA) concluded on Friday 23 July that the use of the Spikevax Covid-19 vaccine developed by the company Moderna could be extended to children aged 12 to 17 years. A study of 3,732 young people found that the antibody response to Spikevax in 12-17 year olds was comparable to that seen in young adults aged 18-25 years. Spikevax is the second vaccine to be so recommended at the European level, following Pfizer/BioNTech’s...

Contents

SECTORAL POLICIES
INSTITUTIONAL
EU RESPONSE TO COVID-19
ECONOMY - FINANCE - BUSINESS
NEWS BRIEFS
CALENDAR